Drugmaker Novo Nordisk announced that the treatment reduced the risk of heart attacks and strokes by a fifth in August, illustrating the treatment's benefits beyond weight loss .
It was previously thought that the weight loss caused the heart-related benefits. Now researchers are considering that Wegovy might have direct heart impacts. READ MORE: FDA approves NEWThe blockbuster weight loss drug Wegovy can reduce the risk of heart attacks and strokes even before significant weight loss has occurred, 'fascinating' results from a major trial suggest.
The study found that 6.5 percent of those who got the drug versus eight percent of those who received the dummy shot had a heart attack or stroke or died from a heart-related cause. The separating of the curves occurred from very early on, before significant weight loss had begun The study, called SELECT, involved over 17,500 patients from 41 countries with no prior history of diabetes.
The study found that 569, or 6.5 percent, of those who got the drug versus 701, or eight percent, of those who received the dummy shot had a heart attack or stroke or died from a heart-related cause. The weight lost from Wegovy might account for some of the differences in rates of heart attacks and strokes, Dr Lincoff said.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Heartbroken tributes to husband with 'huge heart' who provided over 100 jobs“John had a huge heart and had truly been adopted by Rossendale folk. He will be sorely missed by many”
Read more »
Shane MacGowan's Wife Shares Heart-Wrenching Update on Husband's HealthShe is facing 'terrifying fears of loss.'
Read more »
Liberal blood transfusion may reduce recurrence risk, improve survival in heart attack patients with anemiaAn international clinical trial led by physician Jeffrey L. Carson, distinguished professor of medicine at Rutgers Robert Wood Johnson Medical School, found that a liberal blood transfusion given to patients who have had a heart attack and have anemia may reduce the risk of a reoccurrence and improve survival rates.
Read more »
Danny Rohl saw Sheffield Wednesday lose heart for first time in 4-0 defeat to MillwallDanny Rohl says Saturday's 4-0 defeat at home to Millwall was the first time he sensed his side lose heart after conceding the lead.
Read more »
Six new medicines approved in Scotland including first treatment for rare heart conditionThe Scottish Medicines Consortium (SMC) has approved Tafamadis for the treatment of a rare heart condition called amyloidosis cardiomyopathy (ATTR-CM). Pfizer UK said it was 'an important milestone for eligible patients in Scotland'.
Read more »
'Best big brother' told 999 he was dying as he lay bleedingKasey Anderson died aged 24 after being knifed in the heart by 47-year-old girlfriend Natalie Bennett
Read more »